[1] Pettigrew MM, Johnson JK, Harris AD. The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance [J]. Ann Epidemiol, 2016, 26(5): 342-347. [2] Gastmeier P, Geffers C, Herrmann M, et al. Nosocomial infections and infections with multidrug-resistant pathogens frequency and mortality [J]. Dtsc Med Wochenschr, 2016, 141(6): 421-426. [3] 王力红,赵霞,张京利,等. 追踪方法学与PDCA循环管理在医院感染管理质量控制中的应用[J]. 中华医院感染学杂志, 2014, 24(6): 1539-1541. [4] 吴淑梅,黄小兰,任泽娟. 集束化管理策略在多重耐药菌管理中的应用[J]. 中国医院感染控制杂志, 2015, 14(12): 840-842. [5] Heudorf U, F?rber D, Mischler D, et al. [Multidrug-Resistant Organisms (MDRO) in rehabilitation clinics in the Rhine-Main District, Germany, 2014: prevalence and risk factors] [J]. [in German]. Rehabilitation (Stuttg), 2015, 54(5): 339-345. [6] 黄勋,邓子德,倪语星,等. 多重耐药菌医院感染预防与控制中国专家共识[J]. 中国医院感染控制杂志, 2015, 14(1): 1-9. [7] 杨蕾,付强. 医院感染管理质量控制的基本内涵及实施策略[J]. 中国医疗管理科学, 2015, 5(2): 17-22. [8] Mukhopadhyay J. Teicoplanin for treating MRSA pneumonia [J]. BMJ, 2014, 348: g2317. [9] Stojanov M, Blanc DS. Characterization of the staphylococcal cassette chromosome mec insertion site in 108 isolates lacking the mecA gene and identified as methicillin-resistant Staphylococcus aureus by the Xpert MRSA assay. [J]. Eer J Clin Microbiol Infect Dis, 2014, 33(11): 1967-1971. [10] 国家卫生计生委合理用药专家委员会,全国细菌耐药监测网. 2015 年全国细菌耐药监测报告[EB/OL]. [2016-11-3].http://www.carss.cn/Sys/res/file/201512/20151220130134_7741_482f3b7ae95841998a37898e2ab2fa87_2015年监测报告.pdf. [11] Singh H, Thangaraj P, Chakrabarti A. Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management [J]. J Clin Diagn Res, 2013,7(11): 2602-2605. [12] Ren G, Zhou M, Ding N, et al. Analysis on distribution features and drug resistance of clinically isolated Acinetobacter baumannii [J]. Exp Ther Med, 2016, 12(3): 1715-1718. [13] Senok A, Garaween G, Raji A, et al. Genetic relatedness of clinical and environmental Acinetobacter baumanii isolates from an intensive care unit outbreak [J]. J Infection Dev Ctries, 2015, 9(6): 665-669. [14] 陈佰义,何礼贤,胡必杰,等. 中国鲍曼不动杆菌感染诊治与防控专家共识[J]. 中国医药科学, 2012, 2(8): 3-8. [15] 陈玉华,曾翠,龚瑞娥,等. 某三级甲等综合医院多药耐药菌监测与预防控制研究[J]. 中华医院感染学杂志, 2016, 26(1): 200-203. [16] Safari M, Saidijam M, Bahador A, et al. High prevalence of multidrug resistance and metallo-bata-lactamase(MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran [J]. J Res Health Sci, 2013, 13(2): 162-167. [17] 饶丽华,涂建斌,王艳琴,等. 多重耐药鲍曼不动杆菌感染的临床分布及耐药性分析[J]. 实验与检验医学, 2015, 33(6): 730-732. [18] 王正兰,李临平,李雪,等. 多重耐药鲍曼不动杆菌耐药情况及其携带耐消毒剂基因的研究[J]. 实用检验医师杂志, 2015, 7(4): 207-210. [19] Weber DJ, Rutala WA, Miller MB, et al. Role of hospital serface in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species [J]. Am J Infect Control, 2010, 38(5 Suppl 1): S25-S33. |